It looks like you are coming from United States, but the current site you have selected to visit is Italy. Do you want to change sites?

Yes, please. No. Keep me on the current site.

Xylem reports fourth quarter and full-year 2020 earnings

4 febbraio 2021
  • Operational performance exceeds expectations on top and bottom line; quarter sequential gains across all segments and end markets
  • Fourth quarter and full-year revenue of $1.37 billion and $4.88 billion, respectively
  • Fourth quarter 2020 reported net income of $148 million or $0.82 per share; adjusted net income of $145 million or $0.81 per share
  • Full-year 2020 reported net income of $254 million or $1.40 per share; adjusted full-year net income of $374 million or $2.06 per share
  • Strong full-year cash performance of 324% operating cash flow conversion and 181% free cash flow conversion
  • Announces 8% increase in cash dividend, representing the Company’s 10th consecutive annual dividend increase
  • Provides 2021 organic revenue growth guidance range of 3% to 5% and adjusted earnings per share range of $2.35 to $2.60

RYE BROOK, N.Y.--(BUSINESS WIRE)-- Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported fourth quarter revenue of $1.37 billion, and full-year 2020 revenue of $4.88 billion, exceeding expectations on strengthening end-market performance, despite COVID-19 related impacts.

Fourth quarter reported operating margin was 13.0 percent, and adjusted operating margin was 13.8 percent, each declining 120 basis points year-over-year. Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin declined 170 basis points to 18.8 percent. COVID-related impacts and inflation drove the margin decline, exceeding productivity improvements and cost savings. Xylem generated net income of $148 million, or $0.82 per share, and adjusted net income of $145 million, or $0.81 per share, which excludes the impact of restructuring, realignment and special charges.

For the full year, Xylem delivered reported operating margin of 7.5 percent, down 180 basis points versus the prior year, and adjusted operating margin of 10.8 percent, down 310 basis points for the same period. Adjusted EBITDA margin was 16.3 percent, down 320 basis points year-over-year. The margin declines for the full year were driven by the same factors as in the fourth quarter. Full-year reported net income was $254 million, or $1.40 per share, with a reported operating margin of 7.5 percent. Adjusted net income, which excludes the impact of restructuring, realignment and special charges, was $374 million, or $2.06 per share. The Company generated $824 million of operating cash flow, representing a 324 percent conversion, and $641 million of free cash flow, representing a 181 percent conversion.

“Our team again delivered solid operational performance, exceeding expectations across all major indicators, including revenue, margin, and EPS,” said Patrick Decker, president and CEO of Xylem. “We drove better-than-anticipated top-line improvements in all segments, taking full advantage of stabilizing demand, demonstrated by sequential gains globally, and with particularly strong performance in Europe and China. Our improved bottom-line performance reflects effective cost containment and supply chain execution through the pandemic, and over-delivery on our free cash flow conversion commitments on the back of disciplined working capital management.”

“That performance gives us positive momentum entering 2021,” Decker continued, “as our end markets showed encouraging signs of recovery in the fourth quarter, with healthy orders trends and significant backlog growth. We also delivered strong performance with our industry-leading digital portfolio, as the pandemic continues to accelerate customer adoption of digital technologies across the water sector. This clearly positions Xylem well in both the near and long term.”

Xylem announced that its Board of Directors declared a dividend in the amount of $0.28 per share, an increase of 8 percent. The dividend is payable on March 18, 2021, to shareholders of record as of February 18, 2021.

Full-year 2021 Outlook

Xylem forecasts full-year 2021 revenue in the range of $5.16 to $5.26 billion, up 6 to 8 percent on a reported basis and up 3 to 5 percent on an organic basis.

Full-year 2021 adjusted EBITDA margin is expected to be in the range of 16.7 to 17.7 percent and adjusted operating margin is expected to be in the range of 11.5 to 12.5 percent. This results in adjusted earnings per share of $2.35 to $2.60, which represents an increase of 14 to 26 percent from Xylem’s 2020 adjusted results. The Company’s adjusted earnings outlook excludes projected restructuring and realignment costs of approximately $50 to $60 million for the year. Further 2021 planning assumptions are included in Xylem’s fourth quarter 2020 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Fourth Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

  • Fourth quarter 2020 revenue was $616 million, flat organically compared with fourth quarter 2019. This result, achieved despite difficult market conditions, was driven by modest growth in the wastewater utility end market in Europe, Asia and Canada offset by softness in the U.S. industrial market.
  • Fourth quarter reported operating income for the segment was $117 million. Adjusted operating income for the segment, which excludes $7 million of restructuring and realignment, was $124 million, a less than one percent decrease versus the comparable period last year. Reported operating margin for the segment was 19.0 percent, down 70 basis points versus the prior year, and adjusted operating margin was 20.1 percent, down 60 basis points versus prior year. Adjusted EBITDA margin was 22.2 percent, down 70 basis points from the prior year. Productivity benefits, cost control and modest price realization were more than offset by inflation, increased reserves, and unfavorable volume and mix impacts.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial applications.

  • Fourth quarter 2020 Applied Water revenue was $395 million, a one percent decline organically year-over-year. Volume weakness in industrial end markets continued in the quarter, with particular softness in the U.S. and Middle East, partly offset by robust growth in the residential market in the U.S. and China.
  • Fourth quarter reported operating income for the segment was $61 million and adjusted operating income, which excludes $1 million of restructuring and realignment costs, was $62 million, a 5 percent decrease versus the comparable period last year. The segment reported operating margin was 15.4 percent, down 40 basis points versus the prior year period. Adjusted operating margin declined 90 basis points to 15.7 percent. Adjusted EBITDA margin was 17.2 percent, down 170 basis points from the prior year. Productivity benefits, favorable mix and modest price realization were more than offset by inflation and lower volumes.

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.

  • Fourth quarter 2020 Measurement & Control Solutions revenue was $362 million, down 5 percent organically versus the prior year, lapping large project deployments in the U.S. and Middle East. Strong sequential improvement reflects healthy demand in the test business and Advanced Infrastructure Analytics, both of which were up high single digits.
  • Fourth quarter reported operating income for the segment was $14 million, and adjusted operating income, which excludes $2 million of restructuring and realignment costs, was $16 million, a 45 percent decrease versus the comparable period last year. The Measurement & Control Solutions segment reported operating margin was 3.9 percent, down 330 basis points versus the prior year period. Adjusted operating margin of 4.4 percent also decreased 330 basis points over the prior year period. Adjusted EBITDA margin was 14.6 percent, down 350 basis points from the prior year. Strong productivity results and cost savings programs partly offset lower volume, inflation and unfavorable mix.

Supplemental information on Xylem’s fourth quarter 2020 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our more than 16,000 diverse employees delivered revenue of $4.88 billion in 2020. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

Forward-Looking Statements

This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “project,” “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals; or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by the coronavirus (“COVID-19”) pandemic. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: overall industry and economic conditions, including industrial, governmental and private sector spending and the strength of the residential and commercial real estate markets; geopolitical, regulatory, economic and other risks associated with international operations; continued uncertainty around the COVID-19 pandemic’s magnitude, duration and impacts on our business, operations, growth, and financial condition, as well as uncertainty around approved vaccines and the pace of recovery when the pandemic subsides; actual or potential other epidemics, pandemics or global health crises; manufacturing and operating cost increases due to inflation, prevailing price changes, tariffs and other factors; fluctuations in foreign currency exchange rates; disruption, competition and pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; availability of products, parts and raw materials from our supply chain; availability, regulation and interference with radio spectrum used by some of our products; our ability to retain and attract senior management and other key talent; uncertainty related to restructuring and realignment actions and related charges and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; difficulty predicting our financial results, including uncertainties due to the nature of our short- and long-cycle businesses; volatility in our results due to weather conditions; risks relating to products, including defects, security, warranty and liability claims, and recalls; our ability to borrow or refinance our existing indebtedness and the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, competition, and the environment; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth in “Part I Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, “Item 1A. Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and in subsequent filings we may make with the Securities and Exchange Commission. All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED INCOME STATEMENTS (Unaudited)

(In Millions, except per share data)

 

Year Ended December 31,

2020

 

2019

 

2018

Revenue

$

4,876

 

 

$

5,249

 

 

$

5,207

Cost of revenue

3,046

 

 

3,203

 

 

3,181

Gross profit

1,830

 

 

2,046

 

 

2,026

Selling, general and administrative expenses

1,143

 

 

1,158

 

 

1,161

Research and development expenses

187

 

 

191

 

 

189

Restructuring and asset impairment charges

75

 

 

63

 

 

22

Goodwill impairment charge

58

 

 

148

 

 

Operating income

367

 

 

486

 

 

654

Interest expense

77

 

 

67

 

 

82

Other non-operating (expense) income, net

(5

)

 

(4

)

 

13

Gain on sale of businesses

 

 

1

 

 

Income before taxes

285

 

 

416

 

 

585

Income tax expense

31

 

 

15

 

 

36

Net income

254

 

 

401

 

 

549

Earnings per share:

 

 

 

 

 

Basic

$

1.41

 

 

$

2.23

 

 

$

3.05

Diluted

$

1.40

 

 

$

2.21

 

 

$

3.03

Weighted average number of shares:

 

 

 

 

 

Basic

180.1

 

 

180.0

 

 

179.8

Diluted

181.1

 

 

181.2

 

 

181.1

 

XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (Unaudited)

(In Millions, except per share amounts)

 

December 31,

2020

 

2019

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

1,875

 

 

$

724

 

Receivables, less allowances for discounts, returns and credit losses of $46 and $35 in 2020 and 2019, respectively

923

 

 

1,036

 

Inventories

558

 

 

539

 

Prepaid and other current assets

167

 

 

151

 

Total current assets

3,523

 

 

2,450

 

Property, plant and equipment, net

657

 

 

658

 

Goodwill

2,854

 

 

2,839

 

Other intangible assets, net

1,093

 

 

1,174

 

Other non-current assets

623

 

 

589

 

Total assets

$

8,750

 

 

$

7,710

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

569

 

 

$

597

 

Accrued and other current liabilities

787

 

 

628

 

Short-term borrowings and current maturities of long-term debt

600

 

 

276

 

Total current liabilities

1,956

 

 

1,501

 

Long-term debt, net

2,484

 

 

2,040

 

Accrued post-retirement benefits

519

 

 

445

 

Deferred income tax liabilities

242

 

 

310

 

Other non-current accrued liabilities

573

 

 

447

 

Total liabilities

5,774

 

 

4,743

 

 

 

 

 

Stockholders’ equity:

 

 

 

Common stock — par value $0.01 per share:

 

 

 

Authorized 750.0 shares, issued 194.9 and 193.9 shares in 2020 and 2019, respectively

2

 

 

2

 

Capital in excess of par value

2,037

 

 

1,991

 

Retained earnings

1,930

 

 

1,866

 

Treasury stock – at cost 14.5 shares and 13.7 shares in 2020 and 2019, respectively

(588

)

 

(527

)

Accumulated other comprehensive loss

(413

)

 

(375

)

Total stockholders’ equity

2,968

 

 

2,957

 

Non-controlling interest

8

 

 

10

 

Total equity

2,976

 

 

2,967

 

Total liabilities and stockholders’ equity

$

8,750

 

 

$

7,710

 

 

XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (In Millions) (Unaudited)

 

Year Ended December 31,

2020

 

2019

 

2018

Operating Activities

 

 

 

 

 

Net income

$

254

 

 

$

401

 

 

 

$

549

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation

117

 

 

117

 

 

 

117

 

Amortization

134

 

 

140

 

 

 

144

 

Deferred income taxes

(31

)

 

(77

)

 

 

(47

)

Share-based compensation

26

 

 

29

 

 

 

30

 

Restructuring and asset impairment charges

75

 

 

63

 

 

 

22

 

Goodwill impairment charge

58

 

 

148

 

 

 

 

Gain from sale of businesses

 

 

(1

)

 

 

 

Other, net

46

 

 

9

 

 

 

9

 

Payments for restructuring

(36

)

 

(30

)

 

 

(21

)

Contributions to post-retirement benefit plans

(27

)

 

(19

)

 

 

(41

)

Changes in assets and liabilities (net of acquisitions):

 

 

 

 

 

Changes in receivables

109

 

 

(23

)

 

 

(103

)

Changes in inventories

(5

)

 

47

 

 

 

(97

)

Changes in accounts payable

(39

)

 

29

 

 

 

51

 

Changes in accrued liabilities

101

 

 

15

 

 

 

(6

)

Changes in accrued taxes

20

 

 

(13

)

 

 

 

Net changes in other assets and liabilities

22

 

 

4

 

 

 

(21

)

Net Cash — Operating activities

824

 

 

839

 

 

 

586

 

Investing Activities

 

 

 

 

 

Capital expenditures

(183

)

 

(226

)

 

 

(237

)

Acquisitions of businesses and assets, net of cash acquired

 

 

(18

)

 

 

(433

)

Proceeds from sale of businesses

 

 

 

 

 

22

 

Cash received from investments

200

 

 

11

 

 

 

11

 

Cash paid for investments

(200

)

 

(7

)

 

 

(11

)

Cash received from cross-currency swaps

12

 

 

9

 

 

 

 

Other, net

2

 

 

 

 

 

5

 

Net Cash — Investing activities

(169

)

 

(231

)

 

 

(643

)

Financing Activities

 

 

 

 

 

Short-term debt issued, net

359

 

 

281

 

 

 

335

 

Short-term debt repaid, net

(640

)

 

(254

)

 

 

(52

)

Long-term debt issued, net

985

 

 

 

 

 

1

 

Long-term debt repaid, net

 

 

 

 

 

(120

)

Repurchase of common stock

(61

)

 

(40

)

 

 

(59

)

Proceeds from exercise of employee stock options

20

 

 

13

 

 

 

7

 

Dividends paid

(188

)

 

(174

)

 

 

(152

)

Other, net

(2

)

 

(3

)

 

 

 

Net Cash — Financing activities

473

 

 

(177

)

 

 

(40

)

Effect of exchange rate changes on cash

23

 

 

(3

)

 

 

(21

)

Net change in cash and cash equivalents

1,151

 

 

428

 

 

 

(118

)

Cash and cash equivalents at beginning of year

724

 

 

296

 

 

 

414

 

Cash and cash equivalents at end of year

$

1,875

 

 

$

724

 

 

 

$

296

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

Cash paid during the year for:

 

 

 

 

 

Interest

$

77

 

 

$

77

 

 

 

$

78

 

Income taxes (net of refunds received)

$

41

 

 

$

107

 

 

 

$

75

 

 

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflects the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.

"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures, and "Free Cash Flow Conversion" defined as Free Cash Flow divided by net income, excluding the gain on sale of businesses, non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for pension costs.

“Tax-related special items" defined as tax items, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for pension costs.

 
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders
($ Millions)
 

(As Reported - GAAP)

 

(As Adjusted - Organic)

 

Constant Currency

 

 

(A)

 

(B)

 

 

 

(C)

 

(D)

 

(E) = B+C+D

 

(F) = E/A

 

(G) = (E - C) / A

 

 

 

 

 

Change

 

% Change

 

Acquisitions / Divestitures

 

 

 

Change

 

% Change

Orders

 

Orders

 

2020 v. 2019

 

2020 v. 2019

 

 

FX Impact

 

Adj. 2020 v. 2019

 

Adj. 2020 v. 2019

2020

 

2019

Year Ended December 31
 
Xylem Inc.

5,033

5,339

(306

)

(6

%)

4

18

 

(284

)

(5

%)

(5

%)

 
Water Infrastructure

2,134

2,234

(100

)

(4

%)

-

20

 

(80

)

(4

%)

(4

%)

Applied Water

1,483

1,556

(73

)

(5

%)

-

-

 

(73

)

(5

%)

(5

%)

Measurement & Control Solutions

1,416

1,549

(133

)

(9

%)

4

(2

)

(131

)

(8

%)

(9

%)

 
Quarter Ended December 31
 
Xylem Inc.

1,294

1,286

8

 

1

%

4

(31

)

(19

)

(1

%)

(2

%)

 
Water Infrastructure

464

530

(66

)

(12

%)

-

(18

)

(84

)

(16

%)

(16

%)

Applied Water

410

387

23

 

6

%

-

(7

)

16

 

4

%

4

%

Measurement & Control Solutions

420

369

51

 

14

%

4

(6

)

49

 

13

%

12

%

 
Quarter Ended September 30
 
Xylem Inc.

1,246

1,346

(100

)

(7

%)

-

(10

)

(110

)

(8

%)

(8

%)

 
Water Infrastructure

558

586

(28

)

(5

%)

-

(4

)

(32

)

(5

%)

(5

%)

Applied Water

375

376

(1

)

(0

%)

-

(3

)

(4

)

(1

%)

(1

%)

Measurement & Control Solutions

313

384

(71

)

(18

%)

-

(3

)

(74

)

(19

%)

(19

%)

 
Quarter Ended June 30
 
Xylem Inc.

1,232

1,392

(160

)

(11

%)

-

36

 

(124

)

(9

%)

(9

%)

 
Water Infrastructure

598

586

12

 

2

%

-

27

 

39

 

7

%

7

%

Applied Water

326

399

(73

)

(18

%)

-

6

 

(67

)

(17

%)

(17

%)

Measurement & Control Solutions

308

407

(99

)

(24

%)

-

3

 

(96

)

(24

%)

(24

%)

 
Quarter Ended March 31
 
Xylem Inc.

1,261

1,315

(54

)

(4

%)

-

23

 

(31

)

(2

%)

(2

%)

 
Water Infrastructure

514

532

(18

)

(3

%)

-

15

 

(3

)

(1

%)

(1

%)

Applied Water

372

394

(22

)

(6

%)

-

4

 

(18

)

(5

%)

(5

%)

Measurement & Control Solutions

375

389

(14

)

(4

%)

-

4

 

(10

)

(3

%)

(3

%)

 

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
 

(As Reported - GAAP)

 

(As Adjusted - Organic)

 

Constant

Currency

 

 

(A)

 

(B)

 

 

 

(C)

 

(D)

 

(E) = B+C+D

 

(F) = E/A

 

(G) = (E - C) / A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change

 

% Change

 

Acquisitions /

 

 

 

Change

 

% Change

 

 

Revenue

 

Revenue

 

2020 v. 2019

 

2020 v. 2019

 

Divestitures

 

FX Impact

 

Adj. 2020 v. 2019

 

Adj. 2020 v. 2019

 

 

2020

 

2019

Year Ended December 31
 
Xylem Inc.

4,876

5,249

(373

)

(7

%)

2

7

 

(364

)

(7

%)

(7

%)

 
Water Infrastructure

2,079

2,177

(98

)

(5

%)

-

9

 

(89

)

(4

%)

(4

%)

Applied Water

1,434

1,541

(107

)

(7

%)

-

(1

)

(108

)

(7

%)

(7

%)

Measurement & Control Solutions

1,363

1,531

(168

)

(11

%)

2

(1

)

(167

)

(11

%)

(11

%)

 
Quarter Ended December 31
 
Xylem Inc.

1,373

1,371

2

 

0

%

2

(28

)

(24

)

(2

%)

(2

%)

 
Water Infrastructure

616

603

13

 

2

%

-

(15

)

(2

)

(0

%)

(0

%)

Applied Water

395

392

3

 

1

%

-

(7

)

(4

)

(1

%)

(1

%)

Measurement & Control Solutions

362

376

(14

)

(4

%)

2

(6

)

(18

)

(5

%)

(5

%)

 
Quarter Ended September 30
 
Xylem Inc.

1,220

1,296

(76

)

(6

%)

-

(9

)

(85

)

(7

%)

(7

%)

 
Water Infrastructure

524

531

(7

)

(1

%)

-

(4

)

(11

)

(2

%)

(2

%)

Applied Water

364

376

(12

)

(3

%)

-

(3

)

(15

)

(4

%)

(4

%)

Measurement & Control Solutions

332

389

(57

)

(15

%)

-

(2

)

(59

)

(15

%)

(15

%)

 
Quarter Ended June 30
 
Xylem Inc.

1,160

1,345

(185

)

(14

%)

-

25

 

(160

)

(12

%)

(12

%)

 
Water Infrastructure

501

561

(60

)

(11

%)

-

16

 

(44

)

(8

%)

(8

%)

Applied Water

337

394

(57

)

(14

%)

-

6

 

(51

)

(13

%)

(13

%)

Measurement & Control Solutions

322

390

(68

)

(17

%)

-

3

 

(65

)

(17

%)

(17

%)

 
Quarter Ended March 31
 
Xylem Inc.

1,123

1,237

(114

)

(9

%)

-

19

 

(95

)

(8

%)

(8

%)

 
Water Infrastructure

438

482

(44

)

(9

%)

-

12

 

(32

)

(7

%)

(7

%)

Applied Water

338

379

(41

)

(11

%)

-

3

 

(38

)

(10

%)

(10

%)

Measurement & Control Solutions

347

376

(29

)

(8

%)

-

4

 

(25

)

(7

%)

(7

%)

 
Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income
($ Millions)
 
 
 

Q1

 

Q2

 

Q3

 

Q4

 

YTD

2020

 

2019

2020

 

2019

2020

 

2019

2020

 

2019

2020

 

2019

Total Revenue
• Total Xylem

1,123

 

1,237

 

1,160

 

1,345

 

1,220

 

1,296

 

1,373

 

1,371

 

4,876

 

5,249

 

• Water Infrastructure

438

 

482

 

501

 

561

 

524

 

531

 

616

 

603

 

2,079

 

2,177

 

• Applied Water

338

 

379

 

337

 

394

 

364

 

376

 

395

 

392

 

1,434

 

1,541

 

• Measurement & Control Solutions

347

 

376

 

322

 

390

 

332

 

389

 

362

 

376

 

1,363

 

1,531

 

 
Operating Income
• Total Xylem

61

 

109

 

54

 

171

 

73

 

11

 

179

 

195

 

367

 

486

 

• Water Infrastructure

39

 

51

 

73

 

98

 

89

 

97

 

117

 

119

 

318

 

365

 

• Applied Water

47

 

56

 

41

 

62

 

56

 

61

 

61

 

62

 

205

 

241

 

• Measurement & Control Solutions

(12

)

16

 

(46

)

26

 

(62

)

(136

)

14

 

27

 

(106

)

(67

)

• Total Segments

74

 

123

 

68

 

186

 

83

 

22

 

192

 

208

 

417

 

539

 

 
Operating Margin
• Total Xylem

5.4

%

8.8

%

4.7

%

12.7

%

6.0

%

0.8

%

13.0

%

14.2

%

7.5

%

9.3

%

• Water Infrastructure

8.9

%

10.6

%

14.6

%

17.5

%

17.0

%

18.3

%

19.0

%

19.7

%

15.3

%

16.8

%

• Applied Water

13.9

%

14.8

%

12.2

%

15.7

%

15.4

%

16.2

%

15.4

%

15.8

%

14.3

%

15.6

%

• Measurement & Control Solutions

(3.5

%)

4.3

%

(14.3

%)

6.7

%

(18.7

%)

(35.0

%)

3.9

%

7.2

%

(7.8

%)

(4.4

%)

• Total Segments

6.6

%

9.9

%

5.9

%

13.8

%

6.8

%

1.7

%

14.0

%

15.2

%

8.6

%

10.3

%

 
Special Charges
• Total Xylem

-

 

4

 

11

 

-

 

70

 

155

 

-

 

-

 

81

 

159

 

• Water Infrastructure

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

• Applied Water

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

• Measurement & Control Solutions

-

 

4

 

10

 

-

 

69

 

155

 

-

 

-

 

79

 

159

 

• Total Segments

-

 

4

 

10

 

-

 

69

 

155

 

-

 

-

 

79

 

159

 

 
Restructuring & Realignment Costs
• Total Xylem

9

 

20

 

43

 

21

 

15

 

30

 

10

 

11

 

77

 

82

 

• Water Infrastructure

5

 

9

 

8

 

9

 

8

 

7

 

7

 

6

 

28

 

31

 

• Applied Water

2

 

3

 

4

 

4

 

2

 

3

 

1

 

3

 

9

 

13

 

• Measurement & Control Solutions

2

 

8

 

31

 

8

 

5

 

20

 

2

 

2

 

40

 

38

 

• Total Segments

9

 

20

 

43

 

21

 

15

 

30

 

10

 

11

 

77

 

82

 

 
Adjusted Operating Income
• Total Xylem

70

 

133

 

108

 

192

 

158

 

196

 

189

 

206

 

525

 

727

 

• Water Infrastructure

44

 

60

 

81

 

107

 

97

 

104

 

124

 

125

 

346

 

396

 

• Applied Water

49

 

59

 

45

 

66

 

58

 

64

 

62

 

65

 

214

 

254

 

• Measurement & Control Solutions

(10

)

28

 

(5

)

34

 

12

 

39

 

16

 

29

 

13

 

130

 

• Total Segments

83

 

147

 

121

 

207

 

167

 

207

 

202

 

219

 

573

 

780

 

 
Adjusted Operating Margin
• Total Xylem

6.2

%

10.8

%

9.3

%

14.3

%

13.0

%

15.1

%

13.8

%

15.0

%

10.8

%

13.9

%

• Water Infrastructure

10.0

%

12.4

%

16.2

%

19.1

%

18.5

%

19.6

%

20.1

%

20.7

%

16.6

%

18.2

%

• Applied Water

14.5

%

15.6

%

13.4

%

16.8

%

15.9

%

17.0

%

15.7

%

16.6

%

14.9

%

16.5

%

• Measurement & Control Solutions

(2.9

%)

7.4

%

(1.6

%)

8.7

%

3.6

%

10.0

%

4.4

%

7.7

%

1.0

%

8.5

%

• Total Segments

7.4

%

11.9

%

10.4

%

15.4

%

13.7

%

16.0

%

14.7

%

16.0

%

11.8

%

14.9

%

 
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
 
 
 
 
 

Q4 2020

 

Q4 2019

As Reported

Adjustments

Adjusted

 

As Reported

Adjustments

Adjusted

Total Revenue

 

1,373

 

 

-

 

 

1,373

 

 

1,371

 

 

-

 

 

1,371

 

Operating Income

 

179

 

 

10

 

a

 

189

 

 

195

 

 

11

 

a

 

206

 

Operating Margin

 

13.0

%

 

13.8

%

 

14.2

%

 

15.0

%

Interest Expense

 

(21

)

 

-

 

 

(21

)

 

(15

)

 

-

 

 

(15

)

Other Non-Operating Income (Expense)

 

-

 

 

1

 

b

 

1

 

 

(2

)

 

8

 

b

 

6

 

Gain/(Loss) From Sale of Business

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

Income before Taxes

 

158

 

 

11

 

 

169

 

 

178

 

 

19

 

 

197

 

Provision for Income Taxes

 

(10

)

 

(14

)

c

 

(24

)

 

(60

)

 

24

 

c

 

(36

)

Net Income Attributable to Xylem

 

148

 

 

(3

)

 

145

 

 

118

 

 

43

 

 

161

 

Diluted Shares

 

181.5

 

 

181.5

 

 

181.2

 

 

181.2

 

Diluted EPS

$

0.82

 

$

(0.01

)

$

0.81

 

$

0.65

 

$

0.24

 

$

0.89

 

 
Year-over-year currency translation impact on current year diluted EPS

$

0.04

 

$

0.00

 

$

0.04

 

Diluted EPS at Constant Currency

$

0.78

 

$

(0.01

)

$

0.77

 

 
 
 

Q4 YTD 2020

 

Q4 YTD 2019

As Reported

Adjustments

Adjusted

 

As Reported

Adjustments

Adjusted

Total Revenue

 

4,876

 

 

-

 

 

4,876

 

 

5,249

 

 

-

 

 

5,249

 

Operating Income

 

367

 

 

158

 

a

 

525

 

 

486

 

 

241

 

a

 

727

 

Operating Margin

 

7.5

%

 

10.8

%

 

9.3

%

 

13.9

%

Interest Expense

 

(77

)

 

-

 

 

(77

)

 

(67

)

 

-

 

 

(67

)

Other Non-Operating Income (Expense)

 

(5

)

 

5

 

b

 

-

 

 

(4

)

 

19

 

b

 

15

 

Gain/(Loss) From Sale of Businesses

 

-

 

 

-

 

 

-

 

 

1

 

 

(1

)

 

-

 

Income before Taxes

 

285

 

 

163

 

 

448

 

 

416

 

 

259

 

 

675

 

Provision for Income Taxes

 

(31

)

 

(43

)

c

 

(74

)

 

(15

)

 

(113

)

c

 

(128

)

Net Income Attributable to Xylem

 

254

 

 

120

 

 

374

 

 

401

 

 

146

 

 

547

 

Diluted Shares

 

181.1

 

 

181.1

 

 

181.2

 

 

181.2

 

Diluted EPS

$

1.40

 

$

0.66

 

$

2.06

 

$

2.21

 

$

0.81

 

$

3.02

 

 
Year-over-year currency translation impact on current year diluted EPS

$

0.02

 

$

0.01

 

$

0.03

 

Diluted EPS at Constant Currency

$

1.38

 

$

0.65

 

$

2.03

 

a Quarter-to-date: Restructuring & realignment costs of $10 million in 2020 and $11 million in 2019.
 
Year-to-date: Restructuring & realignment costs of $77 million and $82 million in 2020 and 2019, respectively; special charges of $81 million ($79 million of intangible asset and goodwill impairment charges and $2 million of other charges) and $159 million of special charges in 2019 ($158 million of goodwill and asset impairment charges and $1 million of acquisition related costs).
 
b Special non-operating charges consist of pension costs related to the UK pension plan that has been transferred to an annuity in 2020 as part of the planned buyout activities ($1 million and $5 million in 2020, and $6 million and $17 million in 2019, quarter-to-date and year-to-date, respectively). Also, $2 million of other non-operating charges in 2019, both quarter-to-date and year-to-date.
 
c Quarter-to-date: Net tax impact on restructuring & realignment costs of $2 million in both 2020 and 2019, respectively; $1 million of tax on special charges in 2020 and $4 million in 2019; and $11 million and $30 million of positive impact from tax related special Expense adjustments in 2020 and 2019, respectively.
 
Year-to-date:  Net tax impact on restructuring & realignment costs of $17 million and $19 million in 2020 and 2019, respectively; $10 million and $6 million of tax impact on special charges in 2020 and 2019; and $16 million and $88 million of negative impact from tax related special benefit adjustments in 2020 and 2019, respectively.  
 
Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow
($ Millions)
 
 

Q1

 

Q2

 

Q3

 

Q4

 

Year-to-Date

2020

 

2019

 

2020

 

2019

 

2020

 

2019

 

2020

 

2019

 

2020

 

2019

 
Net Cash - Operating Activities

$

(2

)

$

83

 

$

181

 

$

123

 

$

275

 

$

245

 

$

370

 

$

388

 

$

824

 

$

839

 

 
Capital Expenditures - PP&E

 

(32

)

 

(53

)

 

(24

)

 

(40

)

 

(24

)

 

(28

)

 

(29

)

 

(29

)

 

(109

)

 

(150

)

Capital Expenditures - Software

 

(19

)

 

(16

)

 

(20

)

 

(20

)

 

(17

)

 

(18

)

 

(18

)

 

(22

)

 

(74

)

 

(76

)

Capital Expenditures

 

(51

)

 

(69

)

 

(44

)

 

(60

)

 

(41

)

 

(46

)

 

(47

)

 

(51

)

 

(183

)

 

(226

)

 
Free Cash Flow

$

(53

)

$

14

 

$

137

 

$

63

 

$

234

 

$

199

 

$

323

 

$

337

 

$

641

 

$

613

 

 
Net Income

 

38

 

 

79

 

 

31

 

 

139

 

 

37

 

 

65

 

 

148

 

 

118

 

 

254

 

$

401

 

 
Gain/(Loss) from sale of businesses

 

-

 

 

1

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

1

 

 
Restructuring & Realignment Charges - non-cash impairment

 

-

 

 

-

 

 

(17

)

 

-

 

 

(3

)

 

-

 

 

(1

)

 

-

 

 

(21

)

 

-

 

 
Special Charges - non-cash impairment

 

-

 

 

(3

)

 

(10

)

 

-

 

 

(69

)

 

(155

)

 

-

 

 

-

 

 

(79

)

 

(158

)

 
Significant deferred tax benefit/(charge)

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

97

 

 

-

 

 

(33

)

 

-

 

 

64

 

 
Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items

$

38

 

$

81

 

$

58

 

$

139

 

$

109

 

$

123

 

$

149

 

$

151

 

$

354

 

$

494

 

 
Operating Cash Flow Conversion

 

(5

%)

 

105

%

 

584

%

 

88

%

 

743

%

 

377

%

 

250

%

 

329

%

 

324

%

 

209

%

 
Free Cash Flow Conversion

 

(139

%)

 

17

%

 

236

%

 

45

%

 

215

%

 

162

%

 

217

%

 

223

%

 

181

%

 

124

%

 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
 

($ Millions)

 

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

Q1

 

Q2

 

Q3

 

Q4

 

Total

 
Net Income

38

 

31

 

37

 

148

 

254

 

 
Income Tax Expense

4

 

4

 

13

 

10

 

31

 

 
Interest Expense (Income), net

14

 

16

 

20

 

20

 

70

 

Depreciation

29

 

29

 

30

 

29

 

117

 

Amortization

35

 

33

 

33

 

33

 

134

 

EBITDA

120

 

113

 

133

 

240

 

606

 

 
Share-based Compensation

8

 

8

 

3

 

7

 

26

 

 
Restructuring & Realignment

9

 

43

 

15

 

10

 

77

 

 
Special Charges

1

 

13

 

71

 

1

 

86

 

 
Adjusted EBITDA

138

 

177

 

222

 

258

 

795

 

 
Revenue

1,123

 

1,160

 

1,220

 

1,373

 

4,876

 

 
Adjusted EBITDA Margin

12.3

%

15.3

%

18.2

%

18.8

%

16.3

%

 

 

2019

 

 

Q1

 

Q2

 

Q3

 

Q4

 

Total

 
Net Income

79

 

139

 

65

 

118

 

401

 

 
Income Tax Expense (Benefit)

15

 

17

 

(77

)

60

 

15

 

 
Interest Expense (Income), net

17

 

18

 

14

 

13

 

62

 

Depreciation

29

 

29

 

30

 

29

 

117

 

Amortization

35

 

34

 

35

 

36

 

140

 

EBITDA

175

 

237

 

67

 

256

 

735

 

 
Share-based Compensation

9

 

7

 

7

 

6

 

29

 

 
Restructuring & Realignment

20

 

21

 

30

 

11

 

82

 

 
Loss/(Gain) from sale of business

(1

)

-

 

-

 

-

 

(1

)

 
Special Charges

4

 

-

 

166

 

8

 

178

 

 
Adjusted EBITDA

207

 

265

 

270

 

281

 

1,023

 

 
Revenue

1,237

 

1,345

 

1,296

 

1,371

 

5,249

 

 
Adjusted EBITDA Margin

16.7

%

19.7

%

20.8

%

20.5

%

19.5

%

 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Water Infrastructure
($ Millions)
 

 

2020

 

Q1

 

Q2

 

Q3

 

Q4

 

Total

 
Pre-Tax Income

37

 

71

 

85

 

116

 

309

 

 
Interest Expense (Income), net

-

 

(1

)

-

 

-

 

(1

)

Depreciation

11

 

11

 

11

 

11

 

44

 

Amortization

4

 

5

 

2

 

2

 

13

 

EBITDA

52

 

86

 

98

 

129

 

365

 

 
Share-based Compensation

-

 

1

 

-

 

1

 

2

 

 
Restructuring & Realignment

5

 

8

 

8

 

7

 

28

 

 
Adjusted EBITDA

57

 

95

 

106

 

137

 

395

 

 
Revenue

438

 

501

 

524

 

616

 

2,079

 

 
Adjusted EBITDA Margin

13.0

%

19.0

%

20.2

%

22.2

%

19.0

%

 

 

2019

 

Q1

 

Q2

 

Q3

 

Q4

 

Total

 
Pre-Tax Income

50

 

96

 

97

 

117

 

360

 

 
Interest Expense (Income), net

(1

)

1

 

(1

)

-

 

(1

)

Depreciation

11

 

12

 

11

 

10

 

44

 

Amortization

4

 

4

 

4

 

5

 

17

 

EBITDA

64

 

113

 

111

 

132

 

420

 

 
Share-based Compensation

1

 

-

 

-

 

1

 

2

 

 
Restructuring & Realignment

9

 

9

 

7

 

5

 

30

 

 
Adjusted EBITDA

74

 

122

 

118

 

138

 

452

 

 
Revenue

482

 

561

 

531

 

603

 

2,177

 

 
Adjusted EBITDA Margin

15.4

%

21.7

%

22.2

%

22.9

%

20.8

%

 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Applied Water
($ Millions)
 

 

2020

Q1

 

Q2

 

Q3

 

Q4

 

Total

 
Pre-Tax Income

47

 

42

 

55

 

60

 

204

 

 
Interest Expense (Income), net

-

 

-

 

-

 

-

 

-

 

Depreciation

5

 

5

 

6

 

5

 

21

 

Amortization

1

 

-

 

1

 

1

 

3

 

EBITDA

53

 

47

 

62

 

66

 

228

 

 
Share-based Compensation

1

 

1

 

-

 

1

 

3

 

 
Restructuring & Realignment

2

 

4

 

2

 

1

 

9

 

 
Adjusted EBITDA

56

 

52

 

64

 

68

 

240

 

 
Revenue

338

 

337

 

364

 

395

 

1,434

 

 
Adjusted EBITDA Margin

16.6

%

15.4

%

17.6

%

17.2

%

16.7

%

 

 

2019

Q1

 

Q2

 

Q3

 

Q4

 

Total

 
Pre-Tax Income

57

 

62

 

62

 

63

 

244

 

 
Interest Expense (Income), net

-

 

-

 

-

 

(1

)

(1

)

Depreciation

5

 

5

 

5

 

6

 

21

 

Amortization

1

 

1

 

-

 

1

 

3

 

EBITDA

63

 

68

 

67

 

69

 

267

 

 
Share-based Compensation

1

 

-

 

1

 

1

 

3

 

 
Restructuring & Realignment

3

 

4

 

3

 

4

 

14

 

 
Adjusted EBITDA

67

 

72

 

71

 

74

 

284

 

 
Revenue

379

 

394

 

376

 

392

 

1,541

 

 
Adjusted EBITDA Margin

17.7

%

18.3

%

18.9

%

18.9

%

18.4

%

 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Measurement & Control Solutions
($ Millions)
 

 

2020

Q1

 

Q2

 

Q3

 

Q4

 

Total

 
Pre-Tax Income

(13

)

(46

)

(62

)

14

 

(107

)

 
Interest Expense (Income), net

-

 

-

 

-

 

-

 

-

 

Depreciation

9

 

8

 

9

 

9

 

35

 

Amortization

27

 

26

 

27

 

27

 

107

 

EBITDA

23

 

(12

)

(26

)

50

 

35

 

 
Share-based Compensation

2

 

1

 

1

 

1

 

5

 

 
Restructuring & Realignment

2

 

31

 

5

 

2

 

40

 

 
Special Charges

-

 

10

 

69

 

-

 

79

 

 
Adjusted EBITDA

27

 

30

 

49

 

53

 

159

 

 
Revenue

347

 

322

 

332

 

362

 

1,363

 

 
Adjusted EBITDA Margin

7.8

%

9.3

%

14.8

%

14.6

%

11.7

%

 

 

2019

Q1

 

Q2

 

Q3

 

Q4

 

Total

 
Pre-Tax Income

16

 

26

 

(137

)

28

 

(67

)

 
Interest Expense (Income), net

-

 

-

 

-

 

-

 

-

 

Depreciation

9

 

9

 

9

 

10

 

37

 

Amortization

27

 

26

 

27

 

27

 

107

 

EBITDA

52

 

61

 

(101

)

65

 

77

 

 
Share-based Compensation

1

 

2

 

1

 

1

 

5

 

 
Restructuring & Realignment

8

 

8

 

20

 

2

 

38

 

 
Loss/(Gain) from sale of business

(1

)

-

 

-

 

-

 

(1

)

 
Special Charges

4

 

-

 

155

 

-

 

159

 

 
Adjusted EBITDA

64

 

71

 

75

 

68

 

278

 

 
Revenue

376

 

390

 

389

 

376

 

1,531

 

 
Adjusted EBITDA Margin

17.0

%

18.2

%

19.3

%

18.1

%

18.2

%

 

Media
Houston Spencer +1 (914) 323-5723
houston.spencer@xyleminc.com

Investors
Matt Latino +1 (914) 323-5821
matthew.latino@xyleminc.com

Source: Xylem Inc.

Xylem